世界のコンパニオン診断検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Companion Diagnostic Tests Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1501 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、コンパニオン診断検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（タンパク質検出、DNA検出、ハイブリダイゼーション、バイオマーカー、その他）、用途別市場規模（製薬・バイオテクノロジー企業、医療機器企業、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・コンパニオン診断検査の市場動向 ・企業の競争状況、市場シェア ・コンパニオン診断検査の種類別市場規模（タンパク質検出、DNA検出、ハイブリダイゼーション、バイオマーカー、その他） ・コンパニオン診断検査の用途別市場規模（製薬・バイオテクノロジー企業、医療機器企業、研究機関） ・コンパニオン診断検査の北米市場規模2016-2027（アメリカ、カナダ） ・コンパニオン診断検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・コンパニオン診断検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・コンパニオン診断検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・コンパニオン診断検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffman LA Roche Ltd.、QIAGEN, Illumina, Inc.、Abbott、Agilent Technologies, Inc.、Genomic Health, Inc.、BioMerieux SA, BioGenex、AGENDIA NV、Siemens Healthcare GmBH、Thermo Fisher Scientific, Inc.） ・結論

Market Analysis and Insights: Global Companion Diagnostic Tests Market
The global Companion Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostic Tests market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Diagnostic Tests market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Diagnostic Tests market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Diagnostic Tests market.

Global Companion Diagnostic Tests Scope and Market Size
Companion Diagnostic Tests market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Protein Detection
DNA Detection
Hybridization
Biomarker
Others

Segment by Application
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffman LA Roche Ltd.
QIAGEN, Illumina, Inc.
Abbott
Agilent Technologies, Inc.
Genomic Health, Inc.
BioMerieux SA, BioGenex
AGENDIA NV
Siemens Healthcare GmBH
Thermo Fisher Scientific, Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Tests Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Protein Detection
1.2.3 DNA Detection
1.2.4 Hybridization
1.2.5 Biomarker
1.2.6 Others
1.3 Market by Application
1.3.1 Global Companion Diagnostic Tests Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Medical Device Companies
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Companion Diagnostic Tests Market Perspective (2016-2027)
2.2 Companion Diagnostic Tests Growth Trends by Regions
2.2.1 Companion Diagnostic Tests Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Companion Diagnostic Tests Historic Market Share by Regions (2016-2021)
2.2.3 Companion Diagnostic Tests Forecasted Market Size by Regions (2022-2027)
2.3 Companion Diagnostic Tests Industry Dynamic
2.3.1 Companion Diagnostic Tests Market Trends
2.3.2 Companion Diagnostic Tests Market Drivers
2.3.3 Companion Diagnostic Tests Market Challenges
2.3.4 Companion Diagnostic Tests Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Tests Players by Revenue
3.1.1 Global Top Companion Diagnostic Tests Players by Revenue (2016-2021)
3.1.2 Global Companion Diagnostic Tests Revenue Market Share by Players (2016-2021)
3.2 Global Companion Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Tests Revenue
3.4 Global Companion Diagnostic Tests Market Concentration Ratio
3.4.1 Global Companion Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests Revenue in 2020
3.5 Companion Diagnostic Tests Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Tests Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Tests Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Tests Breakdown Data by Type
4.1 Global Companion Diagnostic Tests Historic Market Size by Type (2016-2021)
4.2 Global Companion Diagnostic Tests Forecasted Market Size by Type (2022-2027)

5 Companion Diagnostic Tests Breakdown Data by Application
5.1 Global Companion Diagnostic Tests Historic Market Size by Application (2016-2021)
5.2 Global Companion Diagnostic Tests Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Companion Diagnostic Tests Market Size (2016-2027)
6.2 North America Companion Diagnostic Tests Market Size by Type
6.2.1 North America Companion Diagnostic Tests Market Size by Type (2016-2021)
6.2.2 North America Companion Diagnostic Tests Market Size by Type (2022-2027)
6.2.3 North America Companion Diagnostic Tests Market Size by Type (2016-2027)
6.3 North America Companion Diagnostic Tests Market Size by Application
6.3.1 North America Companion Diagnostic Tests Market Size by Application (2016-2021)
6.3.2 North America Companion Diagnostic Tests Market Size by Application (2022-2027)
6.3.3 North America Companion Diagnostic Tests Market Size by Application (2016-2027)
6.4 North America Companion Diagnostic Tests Market Size by Country
6.4.1 North America Companion Diagnostic Tests Market Size by Country (2016-2021)
6.4.2 North America Companion Diagnostic Tests Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Companion Diagnostic Tests Market Size (2016-2027)
7.2 Europe Companion Diagnostic Tests Market Size by Type
7.2.1 Europe Companion Diagnostic Tests Market Size by Type (2016-2021)
7.2.2 Europe Companion Diagnostic Tests Market Size by Type (2022-2027)
7.2.3 Europe Companion Diagnostic Tests Market Size by Type (2016-2027)
7.3 Europe Companion Diagnostic Tests Market Size by Application
7.3.1 Europe Companion Diagnostic Tests Market Size by Application (2016-2021)
7.3.2 Europe Companion Diagnostic Tests Market Size by Application (2022-2027)
7.3.3 Europe Companion Diagnostic Tests Market Size by Application (2016-2027)
7.4 Europe Companion Diagnostic Tests Market Size by Country
7.4.1 Europe Companion Diagnostic Tests Market Size by Country (2016-2021)
7.4.2 Europe Companion Diagnostic Tests Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Tests Market Size (2016-2027)
8.2 Asia-Pacific Companion Diagnostic Tests Market Size by Type
8.2.1 Asia-Pacific Companion Diagnostic Tests Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Companion Diagnostic Tests Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Companion Diagnostic Tests Market Size by Type (2016-2027)
8.3 Asia-Pacific Companion Diagnostic Tests Market Size by Application
8.3.1 Asia-Pacific Companion Diagnostic Tests Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Companion Diagnostic Tests Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Companion Diagnostic Tests Market Size by Application (2016-2027)
8.4 Asia-Pacific Companion Diagnostic Tests Market Size by Region
8.4.1 Asia-Pacific Companion Diagnostic Tests Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Companion Diagnostic Tests Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Companion Diagnostic Tests Market Size (2016-2027)
9.2 Latin America Companion Diagnostic Tests Market Size by Type
9.2.1 Latin America Companion Diagnostic Tests Market Size by Type (2016-2021)
9.2.2 Latin America Companion Diagnostic Tests Market Size by Type (2022-2027)
9.2.3 Latin America Companion Diagnostic Tests Market Size by Type (2016-2027)
9.3 Latin America Companion Diagnostic Tests Market Size by Application
9.3.1 Latin America Companion Diagnostic Tests Market Size by Application (2016-2021)
9.3.2 Latin America Companion Diagnostic Tests Market Size by Application (2022-2027)
9.3.3 Latin America Companion Diagnostic Tests Market Size by Application (2016-2027)
9.4 Latin America Companion Diagnostic Tests Market Size by Country
9.4.1 Latin America Companion Diagnostic Tests Market Size by Country (2016-2021)
9.4.2 Latin America Companion Diagnostic Tests Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Tests Market Size (2016-2027)
10.2 Middle East & Africa Companion Diagnostic Tests Market Size by Type
10.2.1 Middle East & Africa Companion Diagnostic Tests Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Companion Diagnostic Tests Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Companion Diagnostic Tests Market Size by Type (2016-2027)
10.3 Middle East & Africa Companion Diagnostic Tests Market Size by Application
10.3.1 Middle East & Africa Companion Diagnostic Tests Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Companion Diagnostic Tests Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Companion Diagnostic Tests Market Size by Application (2016-2027)
10.4 Middle East & Africa Companion Diagnostic Tests Market Size by Country
10.4.1 Middle East & Africa Companion Diagnostic Tests Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Companion Diagnostic Tests Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffman LA Roche Ltd.
11.1.1 F. Hoffman LA Roche Ltd. Company Details
11.1.2 F. Hoffman LA Roche Ltd. Business Overview
11.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Introduction
11.1.4 F. Hoffman LA Roche Ltd. Revenue in Companion Diagnostic Tests Business (2016-2021)
11.1.5 F. Hoffman LA Roche Ltd. Recent Development
11.2 QIAGEN, Illumina, Inc.
11.2.1 QIAGEN, Illumina, Inc. Company Details
11.2.2 QIAGEN, Illumina, Inc. Business Overview
11.2.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Introduction
11.2.4 QIAGEN, Illumina, Inc. Revenue in Companion Diagnostic Tests Business (2016-2021)
11.2.5 QIAGEN, Illumina, Inc. Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Companion Diagnostic Tests Introduction
11.3.4 Abbott Revenue in Companion Diagnostic Tests Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Agilent Technologies, Inc.
11.4.1 Agilent Technologies, Inc. Company Details
11.4.2 Agilent Technologies, Inc. Business Overview
11.4.3 Agilent Technologies, Inc. Companion Diagnostic Tests Introduction
11.4.4 Agilent Technologies, Inc. Revenue in Companion Diagnostic Tests Business (2016-2021)
11.4.5 Agilent Technologies, Inc. Recent Development
11.5 Genomic Health, Inc.
11.5.1 Genomic Health, Inc. Company Details
11.5.2 Genomic Health, Inc. Business Overview
11.5.3 Genomic Health, Inc. Companion Diagnostic Tests Introduction
11.5.4 Genomic Health, Inc. Revenue in Companion Diagnostic Tests Business (2016-2021)
11.5.5 Genomic Health, Inc. Recent Development
11.6 BioMerieux SA, BioGenex
11.6.1 BioMerieux SA, BioGenex Company Details
11.6.2 BioMerieux SA, BioGenex Business Overview
11.6.3 BioMerieux SA, BioGenex Companion Diagnostic Tests Introduction
11.6.4 BioMerieux SA, BioGenex Revenue in Companion Diagnostic Tests Business (2016-2021)
11.6.5 BioMerieux SA, BioGenex Recent Development
11.7 AGENDIA NV
11.7.1 AGENDIA NV Company Details
11.7.2 AGENDIA NV Business Overview
11.7.3 AGENDIA NV Companion Diagnostic Tests Introduction
11.7.4 AGENDIA NV Revenue in Companion Diagnostic Tests Business (2016-2021)
11.7.5 AGENDIA NV Recent Development
11.8 Siemens Healthcare GmBH
11.8.1 Siemens Healthcare GmBH Company Details
11.8.2 Siemens Healthcare GmBH Business Overview
11.8.3 Siemens Healthcare GmBH Companion Diagnostic Tests Introduction
11.8.4 Siemens Healthcare GmBH Revenue in Companion Diagnostic Tests Business (2016-2021)
11.8.5 Siemens Healthcare GmBH Recent Development
11.9 Thermo Fisher Scientific, Inc.
11.9.1 Thermo Fisher Scientific, Inc. Company Details
11.9.2 Thermo Fisher Scientific, Inc. Business Overview
11.9.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Introduction
11.9.4 Thermo Fisher Scientific, Inc. Revenue in Companion Diagnostic Tests Business (2016-2021)
11.9.5 Thermo Fisher Scientific, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Companion Diagnostic Tests Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Protein Detection
Table 3. Key Players of DNA Detection
Table 4. Key Players of Hybridization
Table 5. Key Players of Biomarker
Table 6. Key Players of Others
Table 7. Global Companion Diagnostic Tests Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Companion Diagnostic Tests Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Companion Diagnostic Tests Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Companion Diagnostic Tests Market Share by Regions (2016-2021)
Table 11. Global Companion Diagnostic Tests Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Companion Diagnostic Tests Market Share by Regions (2022-2027)
Table 13. Companion Diagnostic Tests Market Trends
Table 14. Companion Diagnostic Tests Market Drivers
Table 15. Companion Diagnostic Tests Market Challenges
Table 16. Companion Diagnostic Tests Market Restraints
Table 17. Global Companion Diagnostic Tests Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Companion Diagnostic Tests Market Share by Players (2016-2021)
Table 19. Global Top Companion Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests as of 2020)
Table 20. Ranking of Global Top Companion Diagnostic Tests Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Companion Diagnostic Tests Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Companion Diagnostic Tests Product Solution and Service
Table 24. Date of Enter into Companion Diagnostic Tests Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Companion Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Companion Diagnostic Tests Revenue Market Share by Type (2016-2021)
Table 28. Global Companion Diagnostic Tests Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Companion Diagnostic Tests Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Companion Diagnostic Tests Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Companion Diagnostic Tests Revenue Market Share by Application (2016-2021)
Table 32. Global Companion Diagnostic Tests Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Companion Diagnostic Tests Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Companion Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Companion Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Companion Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Companion Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Companion Diagnostic Tests Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Companion Diagnostic Tests Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Companion Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Companion Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Companion Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Companion Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Companion Diagnostic Tests Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Companion Diagnostic Tests Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Companion Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Companion Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Companion Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Companion Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Companion Diagnostic Tests Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Companion Diagnostic Tests Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Companion Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Companion Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Companion Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Companion Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Companion Diagnostic Tests Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Companion Diagnostic Tests Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Companion Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Companion Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Companion Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Companion Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Companion Diagnostic Tests Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Companion Diagnostic Tests Market Size by Country (2022-2027) & (US$ Million)
Table 64. F. Hoffman LA Roche Ltd. Company Details
Table 65. F. Hoffman LA Roche Ltd. Business Overview
Table 66. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product
Table 67. F. Hoffman LA Roche Ltd. Revenue in Companion Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 68. F. Hoffman LA Roche Ltd. Recent Development
Table 69. QIAGEN, Illumina, Inc. Company Details
Table 70. QIAGEN, Illumina, Inc. Business Overview
Table 71. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product
Table 72. QIAGEN, Illumina, Inc. Revenue in Companion Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 73. QIAGEN, Illumina, Inc. Recent Development
Table 74. Abbott Company Details
Table 75. Abbott Business Overview
Table 76. Abbott Companion Diagnostic Tests Product
Table 77. Abbott Revenue in Companion Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 78. Abbott Recent Development
Table 79. Agilent Technologies, Inc. Company Details
Table 80. Agilent Technologies, Inc. Business Overview
Table 81. Agilent Technologies, Inc. Companion Diagnostic Tests Product
Table 82. Agilent Technologies, Inc. Revenue in Companion Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 83. Agilent Technologies, Inc. Recent Development
Table 84. Genomic Health, Inc. Company Details
Table 85. Genomic Health, Inc. Business Overview
Table 86. Genomic Health, Inc. Companion Diagnostic Tests Product
Table 87. Genomic Health, Inc. Revenue in Companion Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 88. Genomic Health, Inc. Recent Development
Table 89. BioMerieux SA, BioGenex Company Details
Table 90. BioMerieux SA, BioGenex Business Overview
Table 91. BioMerieux SA, BioGenex Companion Diagnostic Tests Product
Table 92. BioMerieux SA, BioGenex Revenue in Companion Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 93. BioMerieux SA, BioGenex Recent Development
Table 94. AGENDIA NV Company Details
Table 95. AGENDIA NV Business Overview
Table 96. AGENDIA NV Companion Diagnostic Tests Product
Table 97. AGENDIA NV Revenue in Companion Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 98. AGENDIA NV Recent Development
Table 99. Siemens Healthcare GmBH Company Details
Table 100. Siemens Healthcare GmBH Business Overview
Table 101. Siemens Healthcare GmBH Revenue in Companion Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 102. Siemens Healthcare GmBH Recent Development
Table 103. Thermo Fisher Scientific, Inc. Company Details
Table 104. Thermo Fisher Scientific, Inc. Business Overview
Table 105. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product
Table 106. Thermo Fisher Scientific, Inc. Revenue in Companion Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 107. Thermo Fisher Scientific, Inc. Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostic Tests Market Share by Type: 2020 VS 2027
Figure 2. Protein Detection Features
Figure 3. DNA Detection Features
Figure 4. Hybridization Features
Figure 5. Biomarker Features
Figure 6. Others Features
Figure 7. Global Companion Diagnostic Tests Market Share by Application: 2020 VS 2027
Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
Figure 9. Medical Device Companies Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Companion Diagnostic Tests Report Years Considered
Figure 12. Global Companion Diagnostic Tests Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Companion Diagnostic Tests Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Companion Diagnostic Tests Market Share by Regions: 2020 VS 2027
Figure 15. Global Companion Diagnostic Tests Market Share by Regions (2022-2027)
Figure 16. Global Companion Diagnostic Tests Market Share by Players in 2020
Figure 17. Global Top Companion Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Companion Diagnostic Tests Revenue in 2020
Figure 19. Global Companion Diagnostic Tests Revenue Market Share by Type (2016-2021)
Figure 20. Global Companion Diagnostic Tests Revenue Market Share by Type (2022-2027)
Figure 21. North America Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Companion Diagnostic Tests Market Share by Type (2016-2027)
Figure 23. North America Companion Diagnostic Tests Market Share by Application (2016-2027)
Figure 24. North America Companion Diagnostic Tests Market Share by Country (2016-2027)
Figure 25. United States Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Companion Diagnostic Tests Market Share by Type (2016-2027)
Figure 29. Europe Companion Diagnostic Tests Market Share by Application (2016-2027)
Figure 30. Europe Companion Diagnostic Tests Market Share by Country (2016-2027)
Figure 31. Germany Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Companion Diagnostic Tests Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Companion Diagnostic Tests Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Companion Diagnostic Tests Market Share by Region (2016-2027)
Figure 41. China Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Companion Diagnostic Tests Market Share by Type (2016-2027)
Figure 49. Latin America Companion Diagnostic Tests Market Share by Application (2016-2027)
Figure 50. Latin America Companion Diagnostic Tests Market Share by Country (2016-2027)
Figure 51. Mexico Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Companion Diagnostic Tests Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Companion Diagnostic Tests Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Companion Diagnostic Tests Market Share by Country (2016-2027)
Figure 57. Turkey Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Companion Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. F. Hoffman LA Roche Ltd. Revenue Growth Rate in Companion Diagnostic Tests Business (2016-2021)
Figure 61. QIAGEN, Illumina, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2016-2021)
Figure 62. Abbott Revenue Growth Rate in Companion Diagnostic Tests Business (2016-2021)
Figure 63. Agilent Technologies, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2016-2021)
Figure 64. Genomic Health, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2016-2021)
Figure 65. BioMerieux SA, BioGenex Revenue Growth Rate in Companion Diagnostic Tests Business (2016-2021)
Figure 66. AGENDIA NV Revenue Growth Rate in Companion Diagnostic Tests Business (2016-2021)
Figure 67. Siemens Healthcare GmBH Revenue Growth Rate in Companion Diagnostic Tests Business (2016-2021)
Figure 68. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---